-
1 Comment
China Health Group Limited is currently in a long term uptrend where the price is trading 35.4% above its 200 day moving average.
From a valuation standpoint, the stock is 96.2% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 4.3.
China Health Group Limited's total revenue rose by 40.3% to $11M since the same quarter in the previous year.
Its net income has dropped by 58.9% to $-9M since the same quarter in the previous year.
Finally, its free cash flow fell by 31.3% to $-6M since the same quarter in the previous year.
Based on the above factors, China Health Group Limited gets an overall score of 3/5.
| CurrencyCode | HKD |
|---|---|
| ISIN | BMG2107P1059 |
| Exchange | HK |
| Sector | Healthcare |
| Industry | Medical Distribution |
| PE Ratio | None |
|---|---|
| Market Cap | 98M |
| Beta | -1.22 |
| Target Price | None |
| Dividend Yield | None |
China Health Group Limited, an investment holding company, engages in the distribution and services of medical equipment and consumables in the People's Republic of China. The company operates through Distribution and Service in Medical Equipment and Consumables; Hospital Operation and Management Services; Business Service; and Research and Development and Sale of Functional Food segments. It is involved in the distribution and marketing of pharmaceutical products, as well as property investment and factoring services business. The company was formerly known as China HealthCare Holdings Limited and changed its name to China Health Group Limited in September 2015. The company was incorporated in 2001 and is headquartered in Central, Hong Kong.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 0673.HK using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
